
GC12417
KW 3902
Also known as 1,3-dipropyl-8-(3-tricyclo[3.3.1.03,7]nonanyl)-7H-purine-2,6-dione
KW 3902 (KW-3902) is a potent, selective adenosine A1 receptor antagonist that is under development for the treatment of patients with acute congestive heart failure and renal impairment
ChemicalCAS136199-02-5MW356.46FormulaC20H28N4O2
- CAS number
- 136199-02-5
- Molecular weight
- 356.46
- Formula
- C20H28N4O2
- Solubility
- DMF: 20 mg/ml,DMSO: 20 mg/ml,DMSO:PBS (pH 7·2) (1:1): 0·5 mg/ml,Ethanol: 0·5 mg/ml
- InChIKey
- PJBFVWGQFLYWCB-UHFFFAOYSA-N
- Catalogue number
- GC12417
- Brand
- GLPBIO
Computed properties PubChem CID 64627 · XLogP 4.9 · TPSA 69.3 Ų · H-bond donors 1
- XLogP
- 4.9
- TPSA
- 69.3 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Rotatable bonds
- 5
- Heavy atoms
- 26
SMILES CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CC5CC(C3)CC4C5
Computed descriptors from PubChem (CID 64627), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il